Tag Archives: RGEN

A Director at Repligen (NASDAQ: RGEN) is Buying Shares

Yesterday, a Director at Repligen (RGEN – Research Report), Nicolas Barthelemy, bought shares of RGEN for $142.8K. Following Nicolas Barthelemy’s last RGEN Buy transaction on August 31, 2018, the stock climbed by 78.5%. Following this transaction Nicolas Barthelemy’s holding in

Repligen (RGEN) Received its Third Buy in a Row

After Stifel Nicolaus and H.C. Wainwright gave Repligen (NASDAQ: RGEN) a Buy rating last month, the company received another Buy, this time from Leerink Partners. Analyst Puneet Souda maintained a Buy rating on Repligen today and set a price target

H.C. Wainwright Believes Repligen (NASDAQ: RGEN) Won’t Stop Here

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Repligen (RGEN – Research Report) today and set a price target of $143.00. The company’s shares closed last Wednesday at $124.71, close to its 52-week high of $127.00. According to

A Director at Repligen is Exercising Options

Yesterday it was reported that a Director at Repligen (RGEN – Research Report), Thomas F. Ryan, exercised options to sell 7,021 RGEN shares at $41.70 a share, for a total transaction value of $616.7K. Following Thomas F. Ryan’s last RGEN

The CFO of Repligen (NASDAQ: RGEN) is Selling Shares

Yesterday, the CFO of Repligen (RGEN – Research Report), Jon Snodgres, sold shares of RGEN for $94.84K. In addition to Jon Snodgres, 3 other RGEN executives reported Sell trades in the last month. See today’s analyst top recommended stocks >>

A Director at Repligen (NASDAQ: RGEN) is Selling Shares

Yesterday, a Director at Repligen (RGEN – Research Report), John Cox, sold shares of RGEN for $413.5K. This is Cox’s first transaction since reporting a Sell transaction on BIIB back in February 2012 In addition to John Cox, one other